174 related articles for article (PubMed ID: 4136737)
1. Five years' experience with iodine-125 therapy of Graves' disease.
Weidinger P; Johnson PM; Werner SC
Lancet; 1974 Jul; 2(7872):74-7. PubMed ID: 4136737
[No Abstract] [Full Text] [Related]
2. Hypothyroidism following iodine-131 therapy.
Hayes MT
J Nucl Med; 1982 Feb; 23(2):176-9. PubMed ID: 6173470
[No Abstract] [Full Text] [Related]
3. Effect of therapy on serum thyroglobulin levels in patients with Graves' disease.
Uller RP; Van Herle AJ
J Clin Endocrinol Metab; 1978 May; 46(5):747-55. PubMed ID: 95586
[No Abstract] [Full Text] [Related]
4. Serum thyroglobulin in normal subjects and patients with hyperthyroidism due to Graves' disease: effects of T3, iodide, 131I and antithyroid drugs.
Gardner DF; Rothman J; Utiger RD
Clin Endocrinol (Oxf); 1979 Dec; 11(6):585-94. PubMed ID: 93993
[No Abstract] [Full Text] [Related]
5. Graves' Disease: Can It Be Cured?
Wiersinga WM
Endocrinol Metab (Seoul); 2019 Mar; 34(1):29-38. PubMed ID: 30912336
[TBL] [Abstract][Full Text] [Related]
6. [Combination of low doses of 131-iodine and synthetic antithyroid agents for prolonged treatment in Basedow's disease. Apropos of 165 cases].
Mitouze J; Jaffiol C; Baldet L; Ghachem M
Rev Fr Endocrinol Clin; 1972; 13(4):339-61. PubMed ID: 4122472
[No Abstract] [Full Text] [Related]
7. Low-dosage 131-I therapy of thyrotoxicosis (diffuse goiters). A five-year follow-up study.
Cevallos JL; Hagen GA; Maloof F; Chapman EM
N Engl J Med; 1974 Jan; 290(3):141-3. PubMed ID: 4859623
[No Abstract] [Full Text] [Related]
8. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
Chen JJ; Ladenson PW
J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
[TBL] [Abstract][Full Text] [Related]
9. Efficiency analysis of using tailored individual doses of radioiodine and fine tuning using a low-dose antithyroid drug in the treatment of Graves' disease.
Liu CJ; Dong YY; Wang YW; Wang KH; Zeng QY
Nucl Med Commun; 2011 Mar; 32(3):227-32. PubMed ID: 21191313
[TBL] [Abstract][Full Text] [Related]
10. Antithyroid drugs as a factor influencing the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre?
Körber C; Schneider P; Körber-Hafner N; Hänscheid H; Reiners C
Eur J Nucl Med; 2001 Sep; 28(9):1360-4. PubMed ID: 11585295
[TBL] [Abstract][Full Text] [Related]
11. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
Andrade VA; Gross JL; Maia AL
J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up study of compensated low-dose 131I therapy for Graves' disease.
Sridama V; McCormick M; Kaplan EL; Fauchet R; DeGroot LJ
N Engl J Med; 1984 Aug; 311(7):426-32. PubMed ID: 6205272
[TBL] [Abstract][Full Text] [Related]
13. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
Alexander EK; Larsen PR
J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
[TBL] [Abstract][Full Text] [Related]
14. Antithyroid drug treatment prior to radioiodine therapy for Graves' disease: yes or no?
Bogazzi F; Martino E; Bartalena L
J Endocrinol Invest; 2003 Feb; 26(2):174-6. PubMed ID: 12739747
[No Abstract] [Full Text] [Related]
15. T lymphocyte subpopulations in Graves' disease: relationship with clinical conditions.
Bagnasco M; Canonica GW; Ferrini S; Biassoni P; Melioli G; Ferrini O; Giordano G
Acta Endocrinol (Copenh); 1983 Feb; 102(2):213-9. PubMed ID: 6187169
[TBL] [Abstract][Full Text] [Related]
16. Triiodothyronine suppression tests and TSH-releasing hormone tests before and after I- 131 therapy for Graves' disease.
Tamai H; Nakagawa T; Takahashi H; Ohsako N; Fukino O; Shinzato R; Suematsu H; Matsuzuka F; Kuma K; Nagataki S
J Nucl Med; 1980 Mar; 21(3):240-5. PubMed ID: 6892713
[No Abstract] [Full Text] [Related]
17. Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves' disease patients.
Hu RT; Liu DS; Li B
BMC Endocr Disord; 2020 May; 20(1):76. PubMed ID: 32471411
[TBL] [Abstract][Full Text] [Related]
18. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
19. Hyperthyroidism due to Graves-Basedow disease in a woman refractory to thyroid hormones.
González Cabrera N; Kalic AK; Antón Miguel MÁ; Sierra Polo P; Vicente Vicente MÁ
Endocrinol Nutr; 2012 Dec; 59(10):609-11. PubMed ID: 22425314
[No Abstract] [Full Text] [Related]
20. 125I therapy in Graves' disease. Long-term results in 355 patients.
McDougall IR; Greig WR
Ann Intern Med; 1976 Dec; 85(6):720-3. PubMed ID: 1036667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
